Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures

NCT: NCT07271238 · RECRUITING

NCT IDNCT07271238
StatusRECRUITING
Start Date2026-03-03
Completion2026-10-15
SponsorLUMA Vision Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of the study is to collect data on the usability and integration of the VERAFEYE Imaging and Guidance System in adult patients indicated to undergo a standard of care catheter-based ablation procedure for the treatment of Atrial Flutter (AFL), paroxysmal AF (PAF) or persistent AF (perAF). Results from this study may be used to guide development and refinement the VERAFEYE Imaging and Guidance System capabilities.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑